GCTK Stock Overview
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
GlucoTrack, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.53 |
| 52 Week High | US$0.99 |
| 52 Week Low | US$0.13 |
| Beta | 0.30 |
| 1 Month Change | 63.38% |
| 3 Month Change | 159.54% |
| 1 Year Change | 13.92% |
| 3 Year Change | -89.18% |
| 5 Year Change | -75.82% |
| Change since IPO | -99.34% |
Recent News & Updates
Shareholder Returns
| GCTK | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 11.6% | -1.3% | -0.7% |
| 1Y | 13.9% | -2.1% | 22.8% |
Return vs Industry: GCTK exceeded the US Medical Equipment industry which returned -2% over the past year.
Return vs Market: GCTK underperformed the US Market which returned 22.3% over the past year.
Price Volatility
| GCTK volatility | |
|---|---|
| GCTK Average Weekly Movement | 23.5% |
| Medical Equipment Industry Average Movement | 7.5% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in US Market | 16.7% |
| 10% least volatile stocks in US Market | 3.0% |
Stable Share Price: GCTK's share price has been volatile over the past 3 months.
Volatility Over Time: GCTK's weekly volatility has increased from 18% to 23% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 6 | Paul Goode | glucotrack.com |
GlucoTrack, Inc., a medical device company, focuses on designing, developing, and commercializing non-invasive glucose monitoring devices for use by people with diabetes in the United States. It develops GlucoTrack, a non-invasive blood glucose monitor that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021.
GlucoTrack, Inc. Fundamentals Summary
| GCTK fundamental statistics | |
|---|---|
| Market cap | US$14.31m |
| Earnings (TTM) | -US$7.95m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-1.8x
P/E RatioIs GCTK overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| GCTK income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$7.95m |
| Earnings | -US$7.95m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 6.1% |
How did GCTK perform over the long term?
See historical performance and comparison